TULSA reduces tumor volume and PSA levels, improving urinary and sexual function in prostate cancer patients. Five-year TACT study data shows 80% of patients had no significant disease after one year, ...
Francis Medical aims to broaden the reach of its Vanquish water vapor-powered ablation system for prostate cancer.
MINNEAPOLIS and ATLANTA, April 16, 2026 /PRNewswire/ -- Francis Medical, Inc., a privately held medical device company, today announced the continued expansion of its U.S. commercial launch with the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Minimally invasive transperineal laser ablation (TPLA) of the prostate appears effective for benign prostatic hyperplasia (BPH), according to a review published online Sept. 21 in Therapeutic Advances ...
J&J's venture arm JJDC leads financing for Francis Medical's Vanquish prostate ablation system, supporting FDA PMA path for ...
Francis Medical’s water vapour ablation system secured FDA clearance for prostate tissue ablation in November 2025, and is ...
Francis’ ongoing VAPOR 2 single-arm study aims to support a 510(k) application for Vanquish at the FDA this July, with one-year data from 235 patients diagnosed with localized, intermediate-risk ...
Francis Medical's Vanquish wields water vapor to overcome some of the limitations of traditional thermal ablation by applying high pressure in 10-second bursts through a catheter. (Francis Medical) ...
Industry trade associations made the case for revisions to draft guidance on clinical testing recommendations for prostate tissue ablation devices in comments earlier this month. The Medical Imaging & ...